Why asthma might surprisingly protect against poor outcomes in COVID-19

Hugo Farne; Aran Singanayagam

doi:10.1183/13993003.03045-2020

Why asthma might surprisingly protect against poor outcomes in COVID-19

Eur Respir J. 2020 Dec 10;56(6):2003045. doi: 10.1183/13993003.03045-2020. Print 2020 Dec.

Authors

Hugo Farne¹, Aran Singanayagam²

Affiliations

¹ National Heart and Lung Institute, Imperial College, London, UK.
² National Heart and Lung Institute, Imperial College, London, UK a.singanayagam@imperial.ac.uk.

Abstract

Asthma may protect against poor outcomes in COVID-19 due to several possible mechanisms, including altered viral entry receptor expression, inhaled corticosteroid use, chronic inflammation, reduced exposure due to shielding and/or mucus hypersecretion https://bit.ly/3eiXOPP

Publication types

Letter
Comment

MeSH terms

Asthma* / epidemiology
COVID-19*
Hospitalization
Humans
Pandemics
Pneumonia, Viral* / epidemiology
SARS-CoV-2

Abstract

Publication types

MeSH terms

Grants and funding